These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 2252927)

  • 1. Management of "brittle" diabetes with a preprogrammable implanted insulin pump delivering intraperitoneal insulin.
    Wood DF; Goodchild K; Guillou P; Thomas DJ; Johnston DG
    BMJ; 1990 Nov; 301(6761):1143-4. PubMed ID: 2252927
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The management of severe brittle diabetes with "Infusaid" implantable pumps.
    Gill GV; Husband DJ; Wright PD; Sharpe G; Taylor R; Walford S; Marshall SM; Alberti KG
    Diabetes Res; 1986 Mar; 3(3):135-7. PubMed ID: 3709039
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Implantable programmable insulin pumps for the treatment of diabetes.
    Waxman K; Turner D; Nguyen ST; Selam JL; Charles MA
    Arch Surg; 1992 Sep; 127(9):1032-6; discussion 1036-7. PubMed ID: 1387526
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Experience with intraperitoneal insulin infusion from implantable programmable systems in type 1 (insulin-dependent) diabetes mellitus previously treated by external pumps.
    Renard E; Lauton D; Bonifacj C; Costalat G; Jacques D; Bringer J; Jaffiol C
    Diabete Metab; 1993; 19(4):364-71. PubMed ID: 8293863
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Feasibility of intraperitoneal insulin therapy with programmable implantable pumps in IDDM. A multicenter study. The EVADIAC Study Group. Evaluation dans le Diabète du Traitement par Implants Actifs.
    Hanaire-Broutin H; Broussolle C; Jeandidier N; Renard E; Guerci B; Haardt MJ; Lassmann-Vague V
    Diabetes Care; 1995 Mar; 18(3):388-92. PubMed ID: 7555483
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical trial of programmable implantable insulin pump for type I diabetes.
    Selam JL; Micossi P; Dunn FL; Nathan DM
    Diabetes Care; 1992 Jul; 15(7):877-85. PubMed ID: 1516508
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term therapy of IDDM with an implantable insulin pump. The Implantable Insulin Pump Trial Study Group.
    Dunn FL; Nathan DM; Scavini M; Selam JL; Wingrove TG
    Diabetes Care; 1997 Jan; 20(1):59-63. PubMed ID: 9028695
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of intraperitoneal insulin infusion (using implantable pump) and subcutaneous insulin administration: preliminary results of a crossover study.
    Jeandidier N; Pinget M; Keipes M; Louy S; Vetter A; Réville P
    Transplant Proc; 1992 Jun; 24(3):948-9. PubMed ID: 1604678
    [No Abstract]   [Full Text] [Related]  

  • 9. Combined improvements in implantable pump technology and insulin stability allow safe and effective long term intraperitoneal insulin delivery in type 1 diabetic patients: the EVADIAC experience.
    Gin H; Renard E; Melki V; Boivin S; Schaepelynck-Bélicar P; Guerci B; Selam JL; Brun JM; Riveline JP; Estour B; Catargi B;
    Diabetes Metab; 2003 Dec; 29(6):602-7. PubMed ID: 14707889
    [TBL] [Abstract][Full Text] [Related]  

  • 10. French multicentre experience of implantable insulin pumps. The EVADIAC Study Group. Evaluation of Active Implants in Diabetes Society.
    Broussolle C; Jeandidier N; Hanaire-Broutin H
    Lancet; 1994 Feb; 343(8896):514-5. PubMed ID: 7906761
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessing the effectiveness of a 3-month day-and-night home closed-loop control combined with pump suspend feature compared with sensor-augmented pump therapy in youths and adults with suboptimally controlled type 1 diabetes: a randomised parallel study protocol.
    Bally L; Thabit H; Tauschmann M; Allen JM; Hartnell S; Wilinska ME; Exall J; Huegel V; Sibayan J; Borgman S; Cheng P; Blackburn M; Lawton J; Elleri D; Leelarathna L; Acerini CL; Campbell F; Shah VN; Criego A; Evans ML; Dunger DB; Kollman C; Bergenstal RM; Hovorka R
    BMJ Open; 2017 Jul; 7(7):e016738. PubMed ID: 28710224
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A cluster randomised trial, cost-effectiveness analysis and psychosocial evaluation of insulin pump therapy compared with multiple injections during flexible intensive insulin therapy for type 1 diabetes: the REPOSE Trial.
    Heller S; White D; Lee E; Lawton J; Pollard D; Waugh N; Amiel S; Barnard K; Beckwith A; Brennan A; Campbell M; Cooper C; Dimairo M; Dixon S; Elliott J; Evans M; Green F; Hackney G; Hammond P; Hallowell N; Jaap A; Kennon B; Kirkham J; Lindsay R; Mansell P; Papaioannou D; Rankin D; Royle P; Smithson WH; Taylor C
    Health Technol Assess; 2017 Apr; 21(20):1-278. PubMed ID: 28440211
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulin pump therapy with continuous glucose monitoring improves metabolic control in brittle type 1 diabetes.
    Petrovski G; Dimitrovski C; Milenkovic T
    Prilozi; 2007 Jul; 28(1):129-35. PubMed ID: 17921923
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of dual-hormone artificial pancreas, single-hormone artificial pancreas, and conventional insulin pump therapy for glycaemic control in patients with type 1 diabetes: an open-label randomised controlled crossover trial.
    Haidar A; Legault L; Messier V; Mitre TM; Leroux C; Rabasa-Lhoret R
    Lancet Diabetes Endocrinol; 2015 Jan; 3(1):17-26. PubMed ID: 25434967
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Health locus of control and glycosylated haemoglobin concentration of implantable insulin pump recipients in Austria.
    Meize-Grochowski AR
    J Adv Nurs; 1990 Jul; 15(7):804-7. PubMed ID: 2394887
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A recent survey confirms the efficacy and the safety of implanted insulin pumps during long-term use in poorly controlled type 1 diabetes patients.
    Schaepelynck P; Renard E; Jeandidier N; Hanaire H; Fermon C; Rudoni S; Catargi B; Riveline JP; Guerci B; Millot L; Martin JF; Sola A;
    Diabetes Technol Ther; 2011 Jun; 13(6):657-60. PubMed ID: 21470000
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunogenicity of intraperitoneal insulin infusion using programmable implantable devices.
    Jeandidier N; Boivin S; Sapin R; Rosart-Ortega F; Uring-Lambert B; Réville P; Pinget M
    Diabetologia; 1995 May; 38(5):577-84. PubMed ID: 7489841
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Continuous intraperitoneal insulin infusion in patients with 'brittle' diabetes: favourable effects on glycaemic control and hospital stay.
    DeVries JH; Eskes SA; Snoek FJ; Pouwer F; Van Ballegooie E; Spijker AJ; Kostense PJ; Seubert M; Heine RJ
    Diabet Med; 2002 Jun; 19(6):496-501. PubMed ID: 12060062
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Implantation of programmable infusion pumps for insulin delivery in type I diabetic patients.
    Walter H; Günther A; Kronski D; Flaschenträger T; Mehnert H
    Klin Wochenschr; 1989 Jun; 67(11):583-7. PubMed ID: 2747136
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is Pump Therapy for All with Type 1 Diabetes?
    Wilson DM
    Diabetes Technol Ther; 2016 May; 18(5):280-1. PubMed ID: 27159783
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.